Clinical trials: Cardiac Decompensation
- Condition Cardiac Decompensation
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Heart Decompensation
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
Open label study of levosimendan; planned comparison for effectiveness and safety to historic matched case controls from participating sites.
- Trial name
- NCT02973620
- Testing
- Levosimendan
- Sponsor
- Tenax Therapeutics, Inc.